» Articles » PMID: 16139224

The Cdk1 Complex Plays a Prime Role in Regulating N-myc Phosphorylation and Turnover in Neural Precursors

Overview
Journal Dev Cell
Publisher Cell Press
Date 2005 Sep 6
PMID 16139224
Citations 71
Authors
Affiliations
Soon will be listed here.
Abstract

Myc family transcription factors are destabilized by phosphorylation of a conserved amino-terminal GSK-3beta motif. In proliferating cerebellar granule neuron precursors (CGNPs), Sonic hedgehog signaling induces N-myc expression, and N-myc protein is stabilized by insulin-like growth factor-mediated suppression of GSK-3beta. N-myc phosphorylation-mediated degradation is a prerequisite for CGNP growth arrest and differentiation. We investigated whether N-myc phosphorylation and turnover are thus linked to cell cycle exit in primary mouse CGNP cultures and the developing cerebellum. We report that phosphorylation-induced turnover of endogenous N-myc protein in CGNPs increases during mitosis, due to increased priming phosphorylation of N-myc for GSK-3beta. The priming phosphorylation requires the Cdk1 complex, whose cyclin subunits are indirect Sonic hedgehog targets. These findings provide a mechanism for promoting growth arrest in the final cycle of neural precursor proliferation competency, or for resetting the cell cycle in the G1 phase, by destabilizing N-myc in mitosis.

Citing Articles

Targeting the MYCN-MDM2 pathways for cancer therapy: Are they druggable?.

Wang W, Du Y, Datta S, Fowler J, Sang H, Albadari N Genes Dis. 2025; 12(2):101156.

PMID: 39802403 PMC: 11719324. DOI: 10.1016/j.gendis.2023.101156.


Exploring the dynamics and interactions of the N-myc transactivation domain through solution nuclear magnetic resonance spectroscopy.

Rejnowicz E, Batchelor M, Leen E, Ahangar M, Burgess S, Richards M Biochem J. 2024; 481(21):1535-1556.

PMID: 39370942 PMC: 11555651. DOI: 10.1042/BCJ20240248.


Comparison of Neurogenesis Promotion Effects between Cinnamoylquinic Acids in Neural Stem Cells from Adult Mice Brains.

Lin H, Sasaki K, Ferdousi F, Isoda H ACS Chem Neurosci. 2024; .

PMID: 39348888 PMC: 11487612. DOI: 10.1021/acschemneuro.4c00329.


MYCN in human development and diseases.

Nishio Y, Kato K, Oishi H, Takahashi Y, Saitoh S Front Oncol. 2024; 14:1417607.

PMID: 38884091 PMC: 11176553. DOI: 10.3389/fonc.2024.1417607.


Current and future therapeutic strategies for high-grade gliomas leveraging the interplay between epigenetic regulators and kinase signaling networks.

Stitzlein L, Adams J, Stitzlein E, Dudley R, Chandra J J Exp Clin Cancer Res. 2024; 43(1):12.

PMID: 38183103 PMC: 10768151. DOI: 10.1186/s13046-023-02923-7.